Surgical Research Section, Hamad Medical Corporation, Doha, Qatar.
Center of Medicine and Health Sciences, Dresden International University, Dresden, Germany.
Rev Med Virol. 2023 Jan;33(1):e2395. doi: 10.1002/rmv.2395. Epub 2022 Sep 3.
There is overwhelming evidence to suggest that male gender is at a higher risk of developing more severe Covid-19 disease and thus having poorer clinical outcomes. However, the relationship between testosterone (T) and Covid-19 remains unclear with both protective and deleterious effects on different aspects of the disease suggested. Here, we review the current epidemiological and biological evidence on the role of testosterone in the process of SARS-CoV-2 infection and in mediating Covid-19 severity, its potential to serve as a biomarker for risk stratification and discuss the possibility of T supplementation as a treatment or preventative therapy for Covid-19.
有大量证据表明,男性患更严重的 COVID-19 疾病和临床预后较差的风险更高。然而,睾丸激素(T)与 COVID-19 之间的关系尚不清楚,有研究表明它对疾病的不同方面既有保护作用,也有有害作用。在这里,我们回顾了当前关于睾丸激素在 SARS-CoV-2 感染过程中以及在介导 COVID-19 严重程度中的作用的流行病学和生物学证据,探讨了其作为风险分层生物标志物的可能性,并讨论了 T 补充剂作为 COVID-19 治疗或预防疗法的可能性。